Cultural and economic factors that (Mis) shape antibiotic use: The nonpharmacologic basis of therapeutics

Annals of Internal Medicine

Volumn 133, Issue 2, 2000, Pages 128-135

  Avorn, Jerry ^a   Solomon, Daniel H ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

ANTIBIOTIC THERAPY; ARTICLE; CLINICAL PRACTICE; CULTURAL FACTOR; DRUG MISUSE; ECONOMIC ASPECT; PATIENT EDUCATION; PRESCRIPTION; PRIORITY JOURNAL;

EID: 0034682609     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-133-2-200007180-00012     Document Type: Article

References (47)

1. McCaig LF, Hughes JM. Trends in antimicrobial drug prescribing among office-based physicians in the United States. JAMA. 1995;273:214-9.
2. Phelps CE. Bug/drug resistance. Sometimes less is more. Med Care. 1989;27:194-203.
3. Avorn J, Harvey K, Soumerai SB, Herxheimer A, Plumridge R, Bardelay G, et al. Information and education as determinants of antibiotic use: report of Task Force 5. Rev Infect Dis. 1987;9 Suppl 3:S286-96.
4. Katon W, Kleinman A. Doctor-patient negotiation and other social science strategies in patient care. In: Eisenberg L, Kleinman A, eds. The Relevance of Social Science for Medicine. Boston: Reidel; 1980:253-79.
5. Parsons T. The Social System. New York: Free Pr; 1951:428-73.
6. Osler W. Aecquanimitas, 3d ed. New York: McGraw-Hill; 1920:254.
7. Wilson AA, Crane LA, Barrett PH, Gonzales R. Public beliefs and use of antibiotics for acute respiratory illness. J Gen Intern Med. 1999;14:658-62.
8. Howie JG. Clinical judgement and antibiotic use in general practice. Br Med J. 1976;2:1061-4.
9. Stott NC, West RR. Randomised controlled trial of antibiotics in patients with cough and purulent sputum. Br Med J. 1976;2:556-9.
10. Brickfield FX, Carter WH, Johnson RE. Erythromycin in the treatment of acute bronchitis in a community practice. J Fam Pract. 1986;23:119-22.
11. Bell RA, Kravitz RL, Wilkes MS. Direct-to-consumer prescription drug advertising and the public. J Gen Intern Med. 1999;14:651-7.
12. Freidson E. Profession of medicine. New York: Dodd, Mead; 1970.
13. Starr P. The Social Transformation of American Medicine. New York: Basic Books; 1982.
14. Avorn J, Soumerai SB. Improving drug-therapy decisions through educational outreach. A randomized controlled trial of academically based "detailing." N Engl J Med. 1983;308:1457-63.
15. Gonzales R, Barrett PH Jr, Crane LA, Steiner JF. Factors associated with antibiotic use for acute bronchitis. J Gen Intern Med. 1998;13:541-8.
16. Gonzales R, Steiner JF, Sande MA. Antibiotic prescribing for adults with colds, upper respiratory tract infections, and bronchitis by ambulatory care physicians. JAMA. 1997;278:901-4.
17. Metlay JP, Stafford RS, Singer DE. National trends in the use of antibiotics by primary care physicians for adult patients with cough. Arch Intern Med. 1998;158:1813-8.
18. McIsaac WJ, Butler CC. Does clinical error contribute to unnecessary antibiotic use? Med Decis Making. 2000;20:33-8.
19. Watson RL, Dowell SF, Jayaraman M, Keyserling H, Kolczak M, Schwartz B. Antimicrobial use tor pediatric upper respiratory infections: reported practice, actual practice, and parent beliefs. Pediatrics. 1999;104: 1251-7.
20. Farmer P. Social scientists and the new tuberculosis. Soc Sci Med. 1997;44:347-58.
21. Avorn J, Soumerai SB, Taylor W, Wessels MR, Janousek J, Weiner M. Reduction of incorrect antibiotic dosing through a structured educational order form. Arch Intern Med. 1988;148:1720-4.
22. Pestotnik SL, Classen DC, Evans RS, Burke JP. Implementing antibiotic practice guidelines through computer-assisted decision support: clinical and financial outcomes. Ann Intern Med. 1996;124:884-90.
23. Pestotnik SL, Evans RS, Burke JP, Gardner RM, Classen DC. Therapeutic antibiotic monitoring: surveillance using a computerized expert system. Am J Med. 1990;88:43-8.
24. Shojania KG, Yokoe D, Platt R, Fiskio J, Ma'luf N, Bates DW. Reducing vancomycin use utilizing a computer guideline: results of a randomized controlled trial. J Am Med Inform Assoc. 1998;5:554-62.
25. Uttley AH, Collins CH, Naidoo J, George RC. Vancomycin-resistant enterococci [Letter]. Lancet. 1988;1:57-8.
26. Cohen ML. Epidemiology of drug resistance: implications for a post-antimicrobial era. Science. 1992;257:1050-5.
27. Classen DC, Pestotnik SL, Evans RS, Burke JP. Computerized surveillance of adverse drug events in hospital patients. JAMA. 1991;266:2847-51.
28. Office of Technology Assessment. Impacts of Antibiotic-Resistant Bacteria (OTA-H-629). Washington, DC: US Government Printing Office; 1995.
29. Radetsky MS, Istre GR, Johansen TL, Parmelee SW, Lauer BA, Wiesenthal AM, et al. Multiply resistant pneumococcus causing meningitis: its epidemiology with a day-care centre. Lancet. 1981;2:771-3.
30. Robins-Browne RM, Kharsany AB, Koornhof HJ. Antibiotic-resistant pneumococci in hospitalized children. J Hyg (Lond). 1984;93:9-16.
31. Reichler MR, Allphin AA, Breiman RF, Schrieber JR, Arnold JE, McDougal LK, et al. The spread of multiply resistant Streptococcus pneumoniae at a day care center in Ohio. J Infect Dis. 1992;166:1346-53.
32. Duchin JS, Breiman RF, Diamond A, Lipman HB, Block SL, Hedrick JA, et al. High prevalence of multidrug-resistant Streptococcus pneumoniae among children in a rural Kentucky community. Pediatr Infect Dis J. 1995; 14:745-50.
33. Zenni MK, Cheatham SH, Thompson JM, Reed GW, Batson AB, Palmer PS, et al. Streptococcus pneumoniae colonization in the young child: association with otitis media and resistance to penicillin. J Pediatr. 1995;127: 533-7.
34. Jernigan DB, Cetron MS, Breiman RF. Minimizing the impact of drug-resistant Streptococcus pneumoniae (DRSP). A strategy from the DRSP Working Group. JAMA. 1996;275:206-9.
35. Dowell SF, Schwartz B. Resistant pneumococci: protecting patients through judicious use of antibiotics. Am Fam Physician. 1997;55:1647-54.
36. McGowan JE Jr. Antimicrobial resistance in hospital organisms and its relation to antibiotic use. Rev Infect Dis. 1983;5:1033-48.
37. Austin DJ, Kristinsson KG, Anderson RM. The relationship between the volume of antimicrobial consumption in human communities and the frequency of resistance. Proc Natl Acad Sci U S A. 1999;96:1152-6.
38. Faryna A, Wergowske GL, Goldenberg K. Impact of therapeutic guidelines on antibiotic use by residents in primary care clinics. J Gen Intern Med. 1987;2:102-7.
39. Davis DA, Thomson MA, Oxman AD, Haynes RB. Changing physician performance. A systematic review of the effect of continuing medical education strategies. JAMA. 1995;274:700-5.
40. Evans RS, Classen DC, Pestotnik SL, Lundsgaarde HP, Burke JP. Improving empiric antibiotic selection using computer decision support. Arch Intern Med. 1994;154:878-84.
41. Lipsky BA, Baker CA, McDonald LL, Suzuki NT. Improving the appropriateness of vancomycin use by sequential interventions. Am J Infect Control. 1999;27:84-90.
42. Echols RM, Kowalsky SF. The use of an antibiotic order form for antibiotic utilization review: influence on physicians' prescribing patterns. J Infect Dis. 1984;150:803-7.
43. Soumerai SB, Avorn J. Economic and policy analysis of university-based drug "detailing." Med Care. 1986;24:313-31.
44. Ray WA, Schaffner W, Federspiel DF. Persistence of improvement in antibiotic prescribing in office practice. JAMA. 1985;253:1774-6.
45. Everitt DE, Soumerai SB, Avorn J, Klapholz H, Wessels M. Changing surgical antimicrobial prophylaxis practices through education targeted at senior department leaders. Infect Control Hosp Epidemiol. 1990;11:578-83.
46. Levy SB. The Antibiotic Paradox: How Miracle Drugs are Destroying the Miracle. New York: Plenum; 1992.
47. Gonzales R, Steiner JF, Lum A, Barrett PH Jr. Decreasing antibiotic use in ambulatory practice: impact of a multidimensional intervention on the treatment of uncomplicated acute bronchitis in adults. JAMA. 1999;281: 1512-9.